ArticleInternational journal of clinical pediatric dentistry2025
Early Intervention for Malocclusion: Role of Myobrace in Children Aged 6-10 Years.
Article in International journal of clinical pediatric dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims and background: This study investigates the early intervention of class I, II, and III malocclusions in children using the Myobrace appliance. The aim is to evaluate the effectiveness of Myobrace in correcting dental and skeletal malocclusions, specifically focusing on improvements in dental arch alignment, occlusion, and craniofacial growth patterns. Materials and methods: Children with class I, II, and III malocclusions were treated with the Myobrace appliance over a defined period. Various parameters were assessed, including dental arch changes, crossbite correction, craniofacial development, and compliance with the prescribed treatment protocol. Results: The use of Myobrace resulted in significant improvements across all three classes of malocclusion. In class I malocclusion, alignment and space management were enhanced. In class II cases, mandibular advancement and maxillary restraint were observed, contributing to better occlusion. For class III malocclusion, Myobrace was effective in promoting maxillary growth and controlling mandibular overgrowth, resulting in improved anterior crossbite correction. Conclusion: The Myobrace appliance offers an effective early intervention for class I, II, and III malocclusions in children. The study supports its use for improving dental alignment, occlusal function, and craniofacial development. The findings support its use as a noninvasive treatment option to reduce the severity of malocclusions and potentially minimize the need for complex orthodontic procedures later in life. Clinical significance: Myobrace improves dental alignment and occlusion, enhancing oral function and facial esthetics in class I, II, and III malocclusions. It promotes favorable craniofacial development, reducing the need for invasive treatments in the future. Myobrace offers a preventive, noninvasive alternative to traditional braces, simplifying future orthodontic care. How to cite this article: Mareddy AR, Reddy VN, Done V,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.